Unknown

Dataset Information

0

Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment.


ABSTRACT: Oligonucleotide aptamers represent a novel platform for creating ligands with desired specificity, and they offer many potentially significant advantages over monoclonal antibodies in terms of feasibility, cost, and clinical applicability. However, the isolation of high-affinity aptamer ligands from random oligonucleotide pools has been challenging. Although high-throughput sequencing (HTS) promises to significantly facilitate systematic evolution of ligands by exponential enrichment (SELEX) analysis, the enormous datasets generated in the process pose new challenges for identifying those rare, high-affinity aptamers present in a given pool. We show that emulsion PCR preserves library diversity, preventing the loss of rare high-affinity aptamers that are difficult to amplify. We also demonstrate the importance of using reference targets to eliminate binding candidates with reduced specificity. Using a combination of bioinformatics and functional analyses, we show that the rate of amplification is more predictive than prevalence with respect to binding affinity and that the mutational landscape within a cluster of related aptamers can guide the identification of high-affinity aptamer ligands. Finally, we demonstrate the power of this selection process for identifying cross-species aptamers that can bind human receptors and cross-react with their murine orthologs.

SUBMITTER: Levay A 

PROVIDER: S-EPMC4499151 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment.

Levay Agata A   Brenneman Randall R   Hoinka Jan J   Sant David D   Cardone Marco M   Trinchieri Giorgio G   Przytycka Teresa M TM   Berezhnoy Alexey A  

Nucleic acids research 20150524 12


Oligonucleotide aptamers represent a novel platform for creating ligands with desired specificity, and they offer many potentially significant advantages over monoclonal antibodies in terms of feasibility, cost, and clinical applicability. However, the isolation of high-affinity aptamer ligands from random oligonucleotide pools has been challenging. Although high-throughput sequencing (HTS) promises to significantly facilitate systematic evolution of ligands by exponential enrichment (SELEX) ana  ...[more]

Similar Datasets

| S-EPMC3892959 | biostudies-literature
| S-EPMC5844890 | biostudies-literature
| S-EPMC5529100 | biostudies-literature
| S-EPMC6248343 | biostudies-literature
| S-EPMC3519989 | biostudies-literature
| S-EPMC3919026 | biostudies-literature
| S-EPMC2873402 | biostudies-literature
| S-EPMC2651014 | biostudies-literature
| S-EPMC3156379 | biostudies-literature
| S-EPMC6625766 | biostudies-literature